Doğukan Saydan, Medical Oncologist at Hakkari State Hospital, shared a post on X about a paper by Nicole Reh et al. published in JCO Oncology Practice:
“Less than 20% of breast cancer patients join clinical trials.
Why? Fear of the unknown, mistrust of research, and logistical burdens like time & cost.
Addressing these barriers is key to making trials more inclusive.”
Title: “Why I Said No”: Trial-Eligible Patient Perspectives on Declining Breast Cancer Clinical Trial Participation
Authors: Nicole Reh, Mandy Chen, Sindhu R. Dwarampudi, Courtney P. Williams, Nicole Henderson, Gabrielle B. Rocque, and Lily A. Gutnik.
You can read the Full Article in JCO Oncology Practice.
More posts on Breast Cancer on OncoDaily.